4//SEC Filing
Patel Chintu 4
Accession 0001209191-21-070258
CIK 0001723128other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:15 PM ET
Size
7.2 KB
Accession
0001209191-21-070258
Insider Transaction Report
Form 4
Patel Chintu
DirectorCo-CEO
Transactions
- Purchase
Class A Common Stock
2021-12-15$4.13/sh+100,000$413,000→ 462,566 total - Purchase
Class A Common Stock
2021-12-16$4.25/sh+50,000$212,500→ 512,566 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.06 to $4.18. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or of the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.20 to $4.30. The reporting person undertakes to provide the Company, any security holder of the Company, or of the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001737428
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 4:15 PM ET
- Size
- 7.2 KB